Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (10248)	5/28/1999 3:32:00 PM
From: Bluegreen	Read Replies (2) \| Respond to of 17367

SL, keep in mind YOU would know what they are talking about in the synopsis, the general population would give you a blank stare. With your kid at G 8 or more even YOUR thinking might not be up to par. So what is informed consent REALLY worth with your child with G 8 and counting? Gotta trust those clinicians in these circumstances (G 8 or above) gotta trust them. People, full blown Meningo. is nasty, VERY nasty and every SECOND counts. Literally, EVERY second counts. Full blown Meningo. is just as much an emergency as someone losing volume, once again EVERY second counts. Once that cascade is kicked off, yep, every second counts. Now SL, is it ethical to have to wait for informed consent on G 8 or more? What if kid was found on playground and parents couldn't be located for IC quick enough? Should the clinician decide, even if it is a trial? Wouldn't it be much better to have these things decided beforehand when designing the trial, instead of looking at a parent's blank stare? You know it is the kid dying, not the parent. What about the kid's right to have someone with knowledge enough to even make the decision instead of a general population clueless parent? Only my opinions and off the cuff thoughts.

To: Bluegreen who wrote (10248)	5/28/1999 9:05:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Lend me your ears. In June we have another presentation. A New Therapy for Otitis Media with Effusion?" Anyone think the presentation will say BPI is not worth considering as this new therapy? J.J. Grote, Leiden University Medical Center (LUMC), Leiden, The Netherlands, "Endotoxin, and its Relation with Otitis Media with Effusion" M.J. Nell, Leiden University Medical Center (LUMC), Leiden, The Netherlands, "Inhibition of Endotoxin Induced Morphological Changes in the Middle Ear by BPI. A New Therapy for Otitis Media with Effusion?" So we have good news we can count on. Involves children and a big market. True XOMA is far away from trials but the news could help focus attention on the potential for BPI.